Literature DB >> 11850752

Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys.

K Asayama1, K Dobashi, H Hayashibe, K Kodera, N Uchida, T Nakane, T Araki, S Nakazawa.   

Abstract

OBJECTIVE: To determine whether the direct measure of visceral adipose tissue (VAT) by computed tomography (CT) is a superior diagnostic criterion to the anthropometric surrogates and more classical criteria of obesity.
DESIGN: Cross-sectional, clinical study. Obese boys were classified according to the occurrence of abnormal values in either serum triglyceride, alanine aminotransferase or insulin level. A threshold value of each criterion for such metabolic derangement was calculated, using the analysis of receiver operating characteristic (ROC) curve.
SUBJECTS: Seventy-five consecutive outpatient Japanese obese boys, ranging in age from 6 to 14 y, were studied. MEASUREMENTS: Anthropometric indices measured were height, body weight, waist girth, hip girth, triceps and subscapular skinfold thicknesses. Classical criteria for obesity used were percentage overweight (POW), body mass index (BMI) and percentage body fat. Waist girth, sagittal diameter by CT and waist-hip ratio (WHR) were evaluated as anthropometric surrogates for VAT. The areas of total abdominal fat (TAF), VAT and subcutaneous adipose tissue (SAT) were measured by CT at the level of the umbilicus. Clinical blood biochemistry was analyzed in fasting blood samples of obese boys.
RESULTS: Thirty-three boys were classified into a no-complication group, and 42 into a complication group. TAF, VAT and SAT areas were closely associated with age, body size and degree of overweight and adiposity, while VAT/SAT was not. VAT area, sagittal diameter, TAF area and waist girth were closely correlated with alanine aminotransferase, insulin, TG and HDL-C. VAT/SAT, BMI, SAT area, WHR, percentage body fat and POW were less closely associated with these biochemical indices. The descending order of the values of area under the curve for the ROC curves were as follows: VAT>sagittal diameter>TAF>VAT/SAT>waist girth>BMI>WHR>percentage body fat>POW. Both VAT area and VAT/SAT gave >80% of sensitivity and specificity. Among the anthropometric indices studied, the sagittal diameter was the best surrogate of visceral fat measure. The sensitivity and specificity for the rest of the anthropometric indices were in an unsatisfactory range. The threshold values for VAT area, VAT/SAT and sagittal diameter were 58.0 cm(2), 0.276 and 19.2 cm, respectively.
CONCLUSION: The threshold values for VAT area, VAT/SAT and sagittal diameter for detecting biochemical complication in Japanese obese boys were lower than the respective values reported in adults. These values can be used for classifying the obese boys into two types: those with medical problem and those without.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11850752     DOI: 10.1038/sj.ijo.0801865

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  20 in total

1.  Evaluation of the effect of visceral fat area on the distance and angle between the superior mesenteric artery and the aorta.

Authors:  Nilgun Isiksalan Ozbulbul; Mehmet Yurdakul; Hakan Dedeoglu; Muharrem Tola; Tulay Olcer
Journal:  Surg Radiol Anat       Date:  2009-03-12       Impact factor: 1.246

2.  Evaluation of DXA vs. MRI for body composition measures in 1-month olds.

Authors:  D A Fields; A M Teague; K R Short; S D Chernausek
Journal:  Pediatr Obes       Date:  2015-03-27       Impact factor: 4.000

3.  Stronger associations of sagittal abdominal diameter with atherogenic lipoprotein subfractions than waist circumference in middle-aged US white and Japanese men.

Authors:  Katsumi Nakata; Jina Choo; Michael J S Hopson; Hirotsugu Ueshima; J David Curb; Chol Shin; Rhobert W Evans; Takashi Kadowaki; Teruo Otake; Aya Kadota; Syaka Kadowaki; Katsuyuki Miura; Aiman El-Saed; Daniel Edmundowicz; Kim Sutton-Tyrrell; Lewis H Kuller; Akira Sekikawa
Journal:  Metabolism       Date:  2010-07-02       Impact factor: 8.694

4.  Intra-abdominal and subcutaneous abdominal fat as predictors of cardiometabolic risk in a sample of Mexican children.

Authors:  C González-Álvarez; N Ramos-Ibáñez; J Azprioz-Leehan; L Ortiz-Hernández
Journal:  Eur J Clin Nutr       Date:  2017-04-05       Impact factor: 4.016

5.  Probable NAFLD, by ALT levels, and diabetes among Filipino-American women.

Authors:  Charlene A Wong; Maria Rosario G Araneta; Elizabeth Barrett-Connor; John Alcaraz; Donna Castañeda; Carol Macera
Journal:  Diabetes Res Clin Pract       Date:  2007-08-30       Impact factor: 5.602

6.  Insulin-like growth factor-I and insulin-like growth factor binding protein-1 are related to cardiovascular disease biomarkers in obese adolescents.

Authors:  Lorraine E Levitt Katz; Kevin A Gralewski; Pamela Abrams; Preneet C Brar; Paul R Gallagher; Terri H Lipman; Lee J Brooks; Dorit Koren
Journal:  Pediatr Diabetes       Date:  2014-12-10       Impact factor: 4.866

7.  Anthropometrics to Identify Overweight Children at Most Risk for the Development of Cardiometabolic Disease.

Authors:  Corinne A Labyak; David M Janicke; Crystal S Lim; James Colee; Anne E Mathews
Journal:  Infant Child Adolesc Nutr       Date:  2013-12

8.  Establishing abdominal height cut-offs and their association with conventional indices of obesity among Arab children and adolescents.

Authors:  Nasser Al-Daghri; Majed Alokail; Omar Al-Attas; Shaun Sabico; Sudhesh Kumar
Journal:  Ann Saudi Med       Date:  2010 May-Jun       Impact factor: 1.526

9.  Intraperitoneal fat and insulin resistance in obese adolescents.

Authors: 
Journal:  Obesity (Silver Spring)       Date:  2009-08-27       Impact factor: 5.002

10.  Sonographic assessment of abdominal fat distribution in infancy.

Authors:  Susanne Holzhauer; Renate M L Zwijsen; Vincent W V Jaddoe; Guenther Boehm; Henriette A Moll; Paul G Mulder; Veronica A Kleyburg-Linkers; Albert Hofman; Jacqueline C M Witteman
Journal:  Eur J Epidemiol       Date:  2009-07-29       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.